--- title: "MIRM: Robust sales growth and a rich late-stage pipeline position the company for five potential approvals by 2027" type: "News" locale: "en" url: "https://longbridge.com/en/news/291467602.md" description: "Net product sales are projected to reach $660–680M in 2026, driven by strong growth in rare liver and genetic disease medicines. Multiple late-stage pipeline assets, including LIVMARLI, Volixibat, Brelovitug, and Zilurgisertib, are advancing toward regulatory milestones, with five potential approvals or label expansions expected by 2027.Original document: Mirum Pharmaceuticals, Inc. [MIRM] Slides Release — Jul. 1 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source." datetime: "2026-07-01T22:24:09.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/291467602.md) - [en](https://longbridge.com/en/news/291467602.md) - [zh-HK](https://longbridge.com/zh-HK/news/291467602.md) generator: "portal-rs" --- # MIRM: Robust sales growth and a rich late-stage pipeline position the company for five potential approvals by 2027 Net product sales are projected to reach $660–680M in 2026, driven by strong growth in rare liver and genetic disease medicines. Multiple late-stage pipeline assets, including LIVMARLI, Volixibat, Brelovitug, and Zilurgisertib, are advancing toward regulatory milestones, with five potential approvals or label expansions expected by 2027. Original document: Mirum Pharmaceuticals, Inc. \[MIRM\] Slides Release — Jul. 1 2026 **Disclaimer** This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source. ### Related Stocks - [MIRM.US](https://longbridge.com/en/quote/MIRM.US.md) ## Related News & Research - [Mirum Pharmaceuticals Earnings Call Highlights Growth Momentum](https://longbridge.com/en/news/296659640.md) - [Mirum Pharmaceuticals CEO Christopher Peetz melepas saham senilai $1,99 juta](https://longbridge.com/en/news/295584396.md) - [25 rare and beautiful coins that are worth millions](https://longbridge.com/en/news/295960689.md) - [AI isn’t close to curing cancer. This startup says it knows what it will take.](https://longbridge.com/en/news/296352961.md) - [From Bookshelf to Shredder: AI’s Race for Training Data Is Responsible for Destroying Rare and Antique Books](https://longbridge.com/en/news/295954464.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**